Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:39 PM
Ignite Modification Date:
2025-12-24 @ 12:39 PM
NCT ID:
NCT05692661
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed HER2 positive or Triple Negative invasive breast carcinoma.(HER2 positive: immunohistochemistry \[IHC\] 3+ and or fluorescence in situ hybridization \[FISH\] amplified; Triple Negative: estrogen receptor \[ER\] and progesterone receptor \[PR\] \< 1%, HER2 negative \[IHC 1+ or 2+ FISH non-amplified\])
* Age ≥ 18 years and ≤ 80 years.
* The primary tumor must be excised via breast conserving surgery.
* Stage p T1-2 N0 M0
* ECOG performance status ≤2.
Exclusion Criteria:
* Invasive breast cancer not confirmed by pathology.
* Distant metastasis
* Prior thoracic radiation.
* Pregnancy or lactating.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT05692661
Study Brief:
Protocol Section:
NCT05692661